Jacques Leibowitch

3.6k total citations · 1 hit paper
35 papers, 2.5k citations indexed

About

Jacques Leibowitch is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jacques Leibowitch has authored 35 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 13 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Jacques Leibowitch's work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (12 papers) and HIV-related health complications and treatments (9 papers). Jacques Leibowitch is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (12 papers) and HIV-related health complications and treatments (9 papers). Jacques Leibowitch collaborates with scholars based in France, United States and Australia. Jacques Leibowitch's co-authors include Dominique Mathez, Patrice Debré, Brigitte Autran, Christine Katlama, Guislaine Carcelain, Roland Tubiana, Catherine Blanc, John R. David, Robert E. Fowles and D Droz and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jacques Leibowitch

35 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Positive Effects of Combined Antiretroviral Therapy on CD4 ⁺ T Cell Homeostasis and Function in Advanced HIV Disease

1997 1.5k citations Brigitte Autran, Guislaine Carcelain et al. profile →

Peers

Jacques Leibowitch

VIROL

IMMUN

EPIDE

Jan Karel M. Eeftinck Schattenkerk Netherlands

Hiroyu Hatano United States

Jean‐Louis Touraine France

Gilad Doitsh United States

Sarah H. Cheeseman United States

Ajay Wanchu India

Laurence Weiss France

Sudhir Penugonda United States

P T Schellekens Netherlands

JoAnn M. Mican United States

Jan Karel M. Eeftinck Schattenkerk Netherlands

Jacques Leibowitch

1.6k ×1.0

VIROL

1.3k ×1.1

880 ×1.1

IMMUN

849 ×1.2

EPIDE

410 ×1.5

Citations per year, relative to Jacques Leibowitch Jacques Leibowitch (= 1×) peers Jan Karel M. Eeftinck Schattenkerk

Countries citing papers authored by Jacques Leibowitch

Since Specialization

Citations

This map shows the geographic impact of Jacques Leibowitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Leibowitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Leibowitch more than expected).

Fields of papers citing papers by Jacques Leibowitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Leibowitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Leibowitch. The network helps show where Jacques Leibowitch may publish in the future.

Co-authorship network of co-authors of Jacques Leibowitch

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Leibowitch. A scholar is included among the top collaborators of Jacques Leibowitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Leibowitch. Jacques Leibowitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abé, Emuri, et al.. (2014). Plasma and Intracellular Antiretroviral Concentrations in HIV-Infected Patients under Short Cycles of Antiretroviral Therapy. AIDS Research and Treatment. 2014. 1–4. 6 indexed citations

Ganor, Yonatan, Zhicheng Zhou, Juraj Bodo, et al.. (2012). The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages. Mucosal Immunology. 6(4). 776–786. 71 indexed citations

Leibowitch, Jacques, Dominique Mathez, Pierre de Truchis, Christian Perronne, & Jean‐Claude Melchior. (2010). Short cycles of antiretroviral drugs provide intermittent yet effective therapy: a pilot study in 48 patients with chronic HIV infection. The FASEB Journal. 24(6). 1649–1655. 6 indexed citations

Gentil, Christel, Sébastien Le Jan, Josette Philippe, et al.. (2006). Is oxygen a key factor in the lipodystrophy phenotype?. Lipids in Health and Disease. 5(1). 27–27. 17 indexed citations

Petit, Caroline, France Piétri‐Rouxel, Annick Lesne, et al.. (2005). Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis. Mitochondrion. 5(3). 154–161. 9 indexed citations

Petit, Caroline, Dominique Mathez, C. Barthélémy, et al.. (2003). Quantitation of Blood Lymphocyte Mitochondrial DNA for the Monitoring of Antiretroviral Drug–Induced Mitochondrial DNA Depletion. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(4). 461–469. 40 indexed citations

Brussel, Audrey, Dominique Mathez, Rémi Lancar, et al.. (2003). Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection. AIDS. 17(5). 645–652. 60 indexed citations

Levacher, M., F. Bouscarat, Roland Landman, et al.. (2000). Frequency of Cytokine-Producing T Cells in HIV-Infected Patients Treated with Stavudine, Didanosine, and Ritonavir. AIDS Research and Human Retroviruses. 16(17). 1869–1875. 6 indexed citations

Carcelain, Guislaine, Catherine Blanc, Jacques Leibowitch, et al.. (1999). T cell changes after combined nucleoside analogue therapy in HIV primary infection. AIDS. 13(9). 1077–1081. 43 indexed citations

10.

Mathez, Dominique, I. Gorin, Christine Katlama, et al.. (1997). Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.. PubMed. 2(3). 175–83. 30 indexed citations

11.

Menzo, Stefano, Pietro E. Varaldo, Luca Butini, et al.. (1996). Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. Journal of Virology. 70(11). 7603–7613. 77 indexed citations

12.

Pedersen, Court, David A. Cooper, Françoise Brun‐Vézinet, et al.. (1992). The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. AIDS. 6(8). 821–826. 8 indexed citations

13.

Tavera, Catherine, D. Prévot, J. Leung-Tack, et al.. (1992). Cystatin C Levels in Sera of Patients with Human Immunodeficiency Virus Infection. A New Avidin-Biotin ELISA Assay for Its Measurement. Journal of Immunoassay. 13(1). 47–60. 40 indexed citations

14.

Housset, Chantal, Pierre‐Marie Girard, Jacques Leibowitch, et al.. (1990). Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver kupffer cells. Human Pathology. 21(4). 404–408. 58 indexed citations

15.

Gorin, I., et al.. (1989). Successful treatment of the pruritus of human immunodeficiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy. Journal of the American Academy of Dermatology. 20(3). 511–513. 29 indexed citations

16.

Soulez, B., et al.. (1988). Bilan Lipidique et T.N.F. (tumor necrosis factor) chez les sujets VIH+. Médecine et Maladies Infectieuses. 18. 772–772. 1 indexed citations

17.

Gigli, Irma, et al.. (1981). Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.. The Journal of Experimental Medicine. 154(1). 1–12. 27 indexed citations

18.

Leibowitch, Jacques, Marie-Claude Léveillé, & Lise Halbwachs. (1979). [Description of an unusual enzymic activity cleaving the third component of complement].. PubMed. 288(5). 567–9. 1 indexed citations

19.

Halbwachs, Lise, Jacques Leibowitch, & J Hamburger. (1978). Inhibition of Nephritic Factor-Dependent C3 Convertase: Isolation of a Natural Inhibitor of C3 Conversion from the Serum of a Patient with Nephritic Factor and Nephritis. The Journal of Immunology. 120(5). 1776–1777. 1 indexed citations

20.

Fowles, Robert E., et al.. (1973). THE ENHANCEMENT OF MACROPHAGE BACTERIOSTASIS BY PRODUCTS OF ACTIVATED LYMPHOCYTES. The Journal of Experimental Medicine. 138(4). 952–964. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact